Article
Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Apr 2010
Kaira Kyoichi, Horie Yoshiki, Ayabe Eriko, Murakami Haruyasu, Takahashi Toshiaki, Tsuya Asuka, Nakamura Yukiko, Naito Tateaki, Endo Masahiro, Kondo Haruhiko, Nakajima Takashi, Yamamoto Nobuyuki
Abstract excerpt
BACKGROUND: Pulmonary pleomorphic carcinoma is a rare epithelial tumor and has an aggressive clinical course. As few studies of pulmonary pleomorphic carcinoma have been described, the clinicopathological characteristics of the disease remain unclear. Especially, the information on the epidermal growth factor receptor (EGFR) mutation status of pulmonary pleomorphic carcinoma is sparse. METHODS: We retrospectively...
Topics
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- ErbB Receptors
- Female
- Gefitinib
- Humans
- Immunoenzyme Techniques
